Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -0.52% is 100% above its 5-year average of -155.02%, near the high end of its 5-year range (-1607.86%–0.00%).
99.53% above its 12-month average of -110.66%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-06-30): -0.16%.
OPERATING MARGIN
-0.52%
OPERATING MARGIN AVG TTM
-110.66%
OPERATING MARGIN AVG 3Y
-117.34%
OPERATING MARGIN AVG 5Y
-155.02%
OPERATING MARGIN AVG 10Y
-48.15%
OPERATING MARGIN AVG 15Y
-31.51%
OPERATING MARGIN AVG 20Y
-90.87%
CURRENT VS TTM AVG
+99.53%
CURRENT VS 3Y AVG
+99.56%
CURRENT VS 5Y AVG
+99.66%
CURRENT VS 10Y AVG
+98.92%
CURRENT VS 15Y AVG
+98.35%
CURRENT VS 20Y AVG
+99.43%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
InMed Pharmaceuticals Inc.
Market Cap
$7.31M
Operating Margin
-0.52%
TTM Avg
-110.66%
3Y Avg
-117.34%
5Y Avg
-155.02%
Market Cap
$7.36M
Operating Margin
-1942.20%
TTM Avg
-1316.46%
3Y Avg
-1768.86%
5Y Avg
-1413.19%
Market Cap
$7.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-522.59%
5Y Avg
-762.76%
Market Cap
$7.25M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.17M
Operating Margin
-4200.46%
TTM Avg
-2747.44%
3Y Avg
-7258.72%
5Y Avg
-5806.97%
Market Cap
$7.31M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$7.83M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.94M
Operating Margin
-5025.53%
TTM Avg
-3024.64%
3Y Avg
-1688.76%
5Y Avg
-1108.68%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $7.31M | -0.52% | -110.66% | -117.34% | -155.02% |
| Longeveron Inc. (LGVN)vs › | $7.36M | -1942.20% | -1316.46% | -1768.86% | -1413.19% |
| KALA BIO, Inc. (KALA)vs › | $7.36M | 0.00% | 0.00% | -522.59% | -762.76% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.17M | -4200.46% | -2747.44% | -7258.72% | -5806.97% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.31M | 0.00% | 0.00% | -19.45% | -19.45% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.94M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
| Aclarion, Inc. (ACON)vs › | $6.83M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
Gross Margin
14.9%
Operating Margin
-0.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -0.16% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -258.57% |
| 2025-09-30 | -157.45% |
| 2025-06-30 | -137.15% |
| 2025-03-31 | -167.67% |
| 2024-12-31 | -198.46% |
| 2024-09-30 | -138.72% |
| 2024-06-30 | -156.58% |
| 2024-03-31 | -153.18% |
| 2023-12-31 | -137.47% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -20.03% |
| 2023-03-31 | -207.87% |
| 2022-12-31 | -465.12% |
| 2022-09-30 | -1069.29% |
| 2022-06-30 | -592.00% |
| 2022-03-31 | -1143.35% |
| 2021-12-31 | -1607.86% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | -8451.11% |
| 2011-03-31 | -1056.45% |
| 2010-12-31 | -387.02% |
| 2010-09-30 | -549.92% |
| 2010-06-30 | -292.14% |
| 2010-03-31 | -1396.85% |
| 2009-12-31 | -2981.96% |
| 2009-09-30 | -446.96% |
| 2009-06-30 | -328.52% |
| 2009-03-31 | -279.83% |
| 2008-12-31 | -574.27% |
| 2008-09-30 | -340.36% |
| 2008-06-30 | 124.74% |
| 2008-03-31 | -60.61% |
| 2007-12-31 | -67.38% |
| 2007-09-30 | -377.14% |
| 2007-06-30 | 1461.55% |
| 2007-03-31 | -1876.09% |
| 2006-12-31 | -2536.90% |
| 2006-09-30 | -63.80% |
| 2006-06-30 | -17.88% |
| 2006-03-31 | -73.38% |
| 2005-12-31 | -33.80% |
| 2005-09-30 | -46.59% |
| 2005-06-30 | -41.12% |
| 2005-03-31 | -24.80% |
| 2004-12-31 | -33.52% |
| 2004-09-30 | -152.06% |
| 2004-07-31 | -104.29% |
| 2004-04-30 | -45.97% |
| 2004-01-31 | -64.59% |
| 2003-10-31 | -33.39% |
| 2003-07-31 | -262.42% |
| 2003-04-30 | -1461.70% |
| 2003-01-31 | -49151.76% |
| 2002-10-31 | -3922.27% |
